Revista Portuguesa de Cardiologia (English Edition)最新文献

{"title":"Quality of life among adults with repaired tetralogy of fallot: A literature review","authors":"Carolina Rodrigues ,&nbsp;Manuela Silva ,&nbsp;Rui Cerejo ,&nbsp;Rui Rodrigues ,&nbsp;Lídia Sousa ,&nbsp;Conceição Trigo ,&nbsp;Luísa Branco ,&nbsp;Ana Agapito ,&nbsp;José Fragata","doi":"10.1016/j.repce.2021.11.016","DOIUrl":"10.1016/j.repce.2021.11.016","url":null,"abstract":"<div><p>Tetralogy of Fallot (TOF) is the most common cyanotic congenital heart defect. Survival into adulthood is currently expected following surgical repair, leading to a growing population of adults with repaired TOF. In this literature review, we aim to summarize the current state of knowledge on the quality of life of adults with repaired TOF.</p><p>A search was conducted on PubMed and results were reviewed for articles published between January of 2010 and June of 2020. Search terms included “Tetralogy of Fallot”, “repaired”, “adults” and “quality of life”.</p><p>For the subjective health status evaluation, most published studies used Short-Form-36. Most studies agree that physical complex status is poorer for adult patients with repaired TOF than for controls. Mental complex status was also lower. Patients reported similar satisfaction with their lives and levels of social participation. Most patients had a college or university degree. Higher education, male gender and having a partner were positively associated with being employed. Studies found no difference in the proportion of patients that are married or living with a partner, compared to control groups. Patients operated for TOF have a lower reproduction rate compared with the background population.</p><p>A consistent finding of these studies is abnormal physical parameters compared to psychosocial issues. The diverse needs of adults with repaired TOF require a multidisciplinary care, that takes into consideration all aspects that affect their quality of life.</p><p>Despite abnormal physical functional status, it is reassuring that most adult patients with TOF lead independent and productive lives.</p></div>","PeriodicalId":101121,"journal":{"name":"Revista Portuguesa de Cardiologia (English Edition)","volume":"40 12","pages":"Pages 969-974"},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S217420492100369X/pdfft?md5=30f2122973306480d6309f386be9d632&pid=1-s2.0-S217420492100369X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39825085","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Cardiac rehabilitation and risk factor control: Always guaranteed results?","authors":"Marco Ambrosetti","doi":"10.1016/j.repce.2021.11.008","DOIUrl":"10.1016/j.repce.2021.11.008","url":null,"abstract":"","PeriodicalId":101121,"journal":{"name":"Revista Portuguesa de Cardiologia (English Edition)","volume":"40 12","pages":"Pages 921-922"},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2174204921003615/pdfft?md5=187efe2806e45a55f0e9040f1a283c5f&pid=1-s2.0-S2174204921003615-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39737377","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A fresh future forged in fear and failure","authors":"Sílvia Monteiro","doi":"10.1016/j.repce.2021.11.010","DOIUrl":"10.1016/j.repce.2021.11.010","url":null,"abstract":"","PeriodicalId":101121,"journal":{"name":"Revista Portuguesa de Cardiologia (English Edition)","volume":"40 12","pages":"Pages 929-931"},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8673473/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39737379","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Transapical off-pump mitral valve repair with NeoChord implantation: Is less better?","authors":"Gonçalo F. Coutinho","doi":"10.1016/j.repce.2021.11.012","DOIUrl":"10.1016/j.repce.2021.11.012","url":null,"abstract":"","PeriodicalId":101121,"journal":{"name":"Revista Portuguesa de Cardiologia (English Edition)","volume":"40 12","pages":"Pages 943-945"},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2174204921003652/pdfft?md5=1a99f953a55e6e190ae3a55acfc59b54&pid=1-s2.0-S2174204921003652-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39737381","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Transapical off-pump mitral valve repair with NeoChord™ implantation: An early single-center Portuguese experience","authors":"Pedro Gonçalves-Teixeira ,&nbsp;Sara Costa ,&nbsp;Daniel Martins ,&nbsp;Paulo Neves ,&nbsp;José Ribeiro","doi":"10.1016/j.repce.2021.11.011","DOIUrl":"10.1016/j.repce.2021.11.011","url":null,"abstract":"<div><h3>Introduction</h3><p>Transapical off-pump NeoChord DS1000™ implantation is a minimally invasive surgical mitral valve repair (MVr) procedure to treat degenerative mitral regurgitation (MR), which is performed using the NeoChord DS1000™ system with two and three-dimensional transesophageal echocardiographic guidance on a beating heart. It has been demonstrated to be safe and effective in carefully selected patients.</p></div><div><h3>Objective</h3><p>The authors aim to analyze short-term clinical and echocardiographic results after mitral valve repair using the NeoChord™ system.</p></div><div><h3>Methods</h3><p>All patients that underwent transapical off-pump mitral valve repair with NeoChord™ implantation at our center, between December 2017 and December 2019, were included. The procedure was performed by left minithoracotomy, under general anesthesia. All patients presented severe primary MR due to flail/prolapse of one leaflet (anterior or posterior).</p></div><div><h3>Results</h3><p>Eighteen patients were included in the analysis, the mean age was 65±15 years, 72% were male. The mean EuroSCORE II was 1.9±1.6. All patients had New York Heart Association (NYHA) class ≥ II. Mean effective regurgitant orifice area was 1.0±0.4 cm², with a mean regurgitant volume 146±42 mL, and a mean leaflet-to-annulus index of 1.29±0.14. MR was due to leaflet prolapse in 50% (N=9), and flail leaflet in 50% (N=9). Anatomic type A (isolated P2 defect) was the predominant form in 66.5% (N=12). Successful repair, defined by none, trace or mild mitral regurgitation, by implantation of two to four neochordae, was achieved in all 18 patients. No major complications arose intra-procedurally. The median follow-up was 194 days. NYHA class was ≤II in 94.5% patients at six-month follow-up, which represented a significant improvement in symptomatic status (p=0.002). At follow-up, 72% of patients (N=13) had grade ≤2 MR. There was a significant reduction in mean indexed left atrium volume (63±7 mL/m² vs. 45±6 mL/m², p=0.038), mean indexed left ventricular end-diastolic volume (87±7 mL/m² vs. 79±9 ml/m², p=0.001), and pulmonary arterial systolic pressure (44±4 vs. 31±8 mmHg, p=0.002). The re-intervention rate was 11.1% (N=2, both patients underwent reintervention, either a re-do NeoChord™ or conventional MV repair on-pump surgery). No major adverse cardiac or cerebrovascular events were registered.</p></div><div><h3>Conclusions</h3><p>In selected patients, minimally invasive MVr using the NeoChord™ system is safe, effective and reproducible. Early clinical and echocardiographic results suggest a significant symptomatic improvement, sustained MR grade decrease, and favorable left cardiac chamber remodeling, with low re-intervention rates. These results warrant further confirmation in larger cohorts, on longer period of follow-up.</p></div>","PeriodicalId":101121,"journal":{"name":"Revista Portuguesa de Cardiologia (English Edition)","volume":"40 12","pages":"Pages 933-941"},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2174204921003640/pdfft?md5=d678a7f04e728cff70cc8ebbc84541d2&pid=1-s2.0-S2174204921003640-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39737380","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Suboptimal control of cardiovascular risk factors in myocardial infarction survivors in a cardiac rehabilitation program","authors":"Vasco Silva ,&nbsp;Eduardo Matos Vilela ,&nbsp;Lilibeth Campos ,&nbsp;Fátima Miranda ,&nbsp;Susana Torres ,&nbsp;Ana João ,&nbsp;Madalena Teixeira ,&nbsp;Pedro Braga ,&nbsp;Ricardo Fontes-Carvalho","doi":"10.1016/j.repce.2021.11.007","DOIUrl":"10.1016/j.repce.2021.11.007","url":null,"abstract":"<div><h3>Introduction and objectives</h3><p>As short-term mortality continues to decrease after myocardial infarction (MI), secondary prevention strategies attain increasing relevance. This study aimed at assessing the control of cardiovascular (CV) risk factors, including dyslipidemia, hypertension and diabetes, in a contemporary cohort of MI survivors who completed an exercise-based cardiac rehabilitation (EBCR) program.</p></div><div><h3>Methods</h3><p>Observational, retrospective cohort study including patients admitted to a tertiary center with acute MI between November 2012 and April 2017, who completed a phase II EBCR program after discharge. Achievement of low-density lipoprotein (LD) cholesterol, blood pressure and HbA1c guideline recommended targets was assessed. Lipid profile parameters were assessed and compared at three time points (hospitalization, beginning and end of the program).</p></div><div><h3>Results</h3><p>A total of 379 patients were included. Mean age was 58.8±10.6 years; 81% were male. Considering the European Society of Cardiology's guidelines on contemporary data collection, 61%, 87% and 71% achieved the recommended LDL cholesterol, blood pressure and HbA1c targets, respectively, at the end of the program. Combining all three risk factors, 42% achieved the recommended targets. High-sensitivity C-reactive protein decreased between the beginning and the end of the program [0.14 (0.08-0.29) mg/L to 0.12 (0.06-0.26) mg/L; p&lt;0.001].</p></div><div><h3>Conclusion</h3><p>Despite contemporary management strategies, including enrollment in a structured EBCR program, a substantial number of patients presented suboptimal control of CV risk factors. Considering the dyslipidemia, hypertension and diabetes results, less than half of the enrolled individuals achieved the recommended targets. These findings highlight a pivotal unmet need which could be particularly relevant in improving CV outcomes by enhancing secondary prevention profiles.</p></div>","PeriodicalId":101121,"journal":{"name":"Revista Portuguesa de Cardiologia (English Edition)","volume":"40 12","pages":"Pages 911-920"},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2174204921003603/pdfft?md5=9427f8be40386099aa6d3f5f386a4b00&pid=1-s2.0-S2174204921003603-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9207876","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Fighting the pandemic with collaboration at heart: Report from cardiologists in a COVID-19-dedicated Portuguese intensive care unit","authors":"Pedro Ribeiro Queirós ,&nbsp;Daniel Caeiro ,&nbsp;Marta Ponte ,&nbsp;Cláudio Guerreiro ,&nbsp;Marisa Silva ,&nbsp;Sara Pipa ,&nbsp;Ana Lúcia Rios ,&nbsp;Diana Adrião ,&nbsp;Raul Neto ,&nbsp;Pedro Teixeira ,&nbsp;Gualter Silva ,&nbsp;Mariana Silva ,&nbsp;Nuno Dias Ferreira ,&nbsp;Paula Castelões ,&nbsp;Pedro Braga","doi":"10.1016/j.repce.2021.11.009","DOIUrl":"10.1016/j.repce.2021.11.009","url":null,"abstract":"<div><h3>Introduction and objectives</h3><p>The coronavirus disease 2019 (COVID-19) spread quickly around the world. Although mainly a respiratory illness, there is growing interest in non-respiratory manifestations, particularly cardiovascular ones. At our center, mobilization of cardiologists with intensive care training was needed. Our aim is to describe patients with severe COVID-19 admitted to a Portuguese intensive care unit (ICU), the cardiovascular impact of the disease and the experience of cardiologists working in a COVID-19 ICU.</p></div><div><h3>Methods</h3><p>Data from adult patients with COVID-19 admitted to the ICU of Centro Hospitalar de Vila Nova de Gaia/Espinho between 16 March 2020 and 21 April 2020 were analyzed retrospectively.</p></div><div><h3>Results</h3><p>Thirty-five patients were admitted. Mean age was 62.6±6.0 years and 23 (65.7%) were male. Dyslipidemia was the most common cardiovascular risk factor (65.7%, n=23), followed by hypertension (57.1%, n=20). Mean ICU stay time was 15.9±10.0 days. Patients had high rates of mechanical ventilation (88.6%, n=31) and vasopressor support (88.6%, n=31). Low rates of new onset left systolic dysfunction were detected (8.5%, n=2). One patient required venoarterial extra-corporeal membrane oxygenation. Mortality was 25% (n=9). Acute myocardial injury and N-terminal pro-B-type natriuretic peptide (NT-proBNP) elevation was detected in 62.9% (n=22). Patients that died had higher NT-proBNP compared to those discharged alive (p&lt;0.05). Care by cardiologists frequently changed decision making.</p></div><div><h3>Conclusions</h3><p>The cardiovascular impact of COVID-19 seems relevant but is still widely unknown. Studies are needed to clarify the role of cardiac markers in COVID-19 prognosis. Multidisciplinary care most likely results in improved patient care.</p></div>","PeriodicalId":101121,"journal":{"name":"Revista Portuguesa de Cardiologia (English Edition)","volume":"40 12","pages":"Pages 923-928"},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8673477/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39737378","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Chronotropism during exercise. Methodological and conceptual inconsistencies","authors":"Miguel Mendes","doi":"10.1016/j.repce.2021.10.028","DOIUrl":"10.1016/j.repce.2021.10.028","url":null,"abstract":"","PeriodicalId":101121,"journal":{"name":"Revista Portuguesa de Cardiologia (English Edition)","volume":"40 12","pages":"Pages 955-956"},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2174204921003524/pdfft?md5=f4d4f51745d0eec720be87835128e3c3&pid=1-s2.0-S2174204921003524-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39737383","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Face masks and exercise: Novel insights into a contemporary conundrum","authors":"Eduardo M. Vilela ,&nbsp;Ricardo Fontes-Carvalho","doi":"10.1016/j.repce.2021.11.015","DOIUrl":"10.1016/j.repce.2021.11.015","url":null,"abstract":"","PeriodicalId":101121,"journal":{"name":"Revista Portuguesa de Cardiologia (English Edition)","volume":"40 12","pages":"Pages 965-967"},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8673476/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39825084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Optimization of heart failure with reduced ejection fraction prognosis-modifying drugs: A 2021 heart failure expert consensus paper","authors":"José Silva-Cardoso ,&nbsp;Cândida Fonseca ,&nbsp;Fátima Franco ,&nbsp;João Morais ,&nbsp;Jorge Ferreira ,&nbsp;Dulce Brito","doi":"10.1016/j.repce.2021.11.017","DOIUrl":"10.1016/j.repce.2021.11.017","url":null,"abstract":"<div><p>Heart failure (HF) with reduced ejection fraction (HFrEF) is associated with high rates of hospitalization and death. It also has a negative impact on patients’ functional capacity and quality of life, as well as on healthcare costs. In recent years, new HFrEF prognosis-modifying drugs have emerged, leading to intense debate within the international scientific community toward a paradigm shift for the management of HFrEF. In this article, we report the contribution of a Portuguese HF expert panel to the ongoing debate.</p><p>Based on the most recently published clinical evidence, and the panel members’ clinical judgment, three key principles are highlighted: (i) sacubitril/valsartan should be preferred as first-line therapy for HFrEF, instead of an angiotensin-converting enzyme inhibitor or angiotensin receptor blocker; (ii) the four foundation HFrEF drugs are the angiotensin receptor/neprilysin inhibitor, beta-adrenergic blocking agents, mineralocorticoid receptor antagonists, and sodium-glucose co-transporter 2 inhibitors, regardless of the presence of type-2 diabetes mellitus; (iii) these four HFrEF drug classes should be introduced over a short-term period of four to six weeks, guided by a safety protocol, followed by a dose up-titration period of 8 weeks.</p></div>","PeriodicalId":101121,"journal":{"name":"Revista Portuguesa de Cardiologia (English Edition)","volume":"40 12","pages":"Pages 975-983"},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2174204921003706/pdfft?md5=6d32d351e1de77e27cc18f41bc6f8cd4&pid=1-s2.0-S2174204921003706-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39825540","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}